| Schedule of restricted stock shares activity |
Activity related to the Company’s equity compensation, which includes the Company’s restricted stock units (“RSUs”) and performance stock units (“PSUs”), was as follows:
| | | | | | | | | | | | | (in thousands, except weighted average grant price) | Number of Shares | | Weighted Average Grant Price | Outstanding awards, December 31, 2024 | 875 | | | $ | 20.63 | | | Granted | 751 | | | 12.05 | | | Vested | (345) | | | 20.70 | | | Forfeited | (35) | | | 16.67 | | Outstanding awards, June 30, 2025 | 1,246 | | | 15.55 | |
Activity related to the Company’s Relative Total Shareholder Return RSUs (“RTSRs”) was as follows:
| | | | | | | | | | | | | (in thousands, except weighted average grant price) | Number of Shares | | Weighted Average Grant Price | Outstanding awards, December 31, 2024 | 259 | | | $ | 22.96 | | | Granted | 241 | | | 12.31 | | | Vested | — | | | — | | | Forfeited | (22) | | | 18.06 | | Outstanding awards, June 30, 2025 | 478 | | | 17.82 | |
|
| Schedule of stock compensation expense |
Stock-based compensation expense was as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
June 30, | | Six Months Ended
June 30, | | (in thousands) | 2025 | | 2024 | | 2025 | | 2024 | | Stock compensation expense | $ | 2,493 | | | $ | 2,538 | | | $ | 6,390 | | | $ | 6,673 | | | Capitalized stock compensation | (306) | | | (268) | | | (486) | | | (437) | | | Stock compensation expense, net | $ | 2,187 | | | $ | 2,270 | | | $ | 5,904 | | | $ | 6,236 | |
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
The following table indicates the computation of basic and diluted earnings (loss) per share:
| | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
June 30, | | Six Months Ended
June 30, | | (in thousands, except per share amounts) | 2025 | | 2024 | | 2025 | | 2024 | | Calculation of net (loss) income per share: | | | | | | | | | Loss from continuing operations | $ | (9,048) | | | $ | (12,773) | | | $ | (18,180) | | | $ | (16,863) | | | Total (loss) income from discontinued operations, net of tax | — | | | (99) | | | — | | | 218,687 | | | Net (loss) income | $ | (9,048) | | | $ | (12,872) | | | $ | (18,180) | | | $ | 201,824 | | | | | | | | | | Amounts attributable to common shareholders | | | | | | | | | Loss from continuing operations | $ | (10,545) | | | $ | (12,773) | | | $ | (21,149) | | | $ | (16,863) | | Total (loss) income from discontinued operations | — | | | (99) | | | — | | | 218,687 | | | Net (loss) income attributable to common shareholders | $ | (10,545) | | | $ | (12,872) | | | $ | (21,149) | | | $ | 201,824 | | | | | | | | | | | Basic and diluted weighted average shares outstanding | 55,103 | | | 54,730 | | | 55,032 | | | 52,620 | | | | | | | | | | Per share amounts attributable to common shareholders | | | | | | | | | Loss from continuing operations | $ | (0.19) | | | $ | (0.24) | | | $ | (0.38) | | | $ | (0.32) | | | (Loss) income from discontinued operations, net of tax | — | | | — | | | — | | | 4.16 | | | Net (loss) income per share | $ | (0.19) | | | $ | (0.24) | | | $ | (0.38) | | | $ | 3.84 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
June 30, | | Six Months Ended
June 30, | | (in thousands) | 2025 | | 2024 | | 2025 | | 2024 | Potentially dilutive equity awards | 436 | | | 392 | | | 431 | | | 444 | | Potentially dilutive shares related to the Series A Preferred Stock | 3,553 | | | 3,306 | | | 3,553 | | | 3,306 | | | Total potentially dilutive instruments | 3,989 | | | 3,698 | | | 3,984 | | | 3,750 | |
|